BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 26976583)

  • 21. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome.
    Schreurs M; Kuipers F; van der Leij FR
    Obes Rev; 2010 May; 11(5):380-8. PubMed ID: 19694967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soraphen, an inhibitor of the acetyl-CoA carboxylase system, improves peripheral insulin sensitivity in mice fed a high-fat diet.
    Schreurs M; van Dijk TH; Gerding A; Havinga R; Reijngoud DJ; Kuipers F
    Diabetes Obes Metab; 2009 Oct; 11(10):987-91. PubMed ID: 19519866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition.
    Harwood HJ
    Expert Opin Ther Targets; 2005 Apr; 9(2):267-81. PubMed ID: 15934915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1/2 inhibitors.
    Chen L; Duan Y; Wei H; Ning H; Bi C; Zhao Y; Qin Y; Li Y
    Expert Opin Investig Drugs; 2019 Oct; 28(10):917-930. PubMed ID: 31430206
    [No Abstract]   [Full Text] [Related]  

  • 26. Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription.
    Zhao LF; Iwasaki Y; Zhe W; Nishiyama M; Taguchi T; Tsugita M; Kambayashi M; Hashimoto K; Terada Y
    Endocr J; 2010; 57(4):317-24. PubMed ID: 20139635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.
    Tomas E; Tsao TS; Saha AK; Murrey HE; Zhang Cc Cc; Itani SI; Lodish HF; Ruderman NB
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16309-13. PubMed ID: 12456889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression, purification, and characterization of human and rat acetyl coenzyme A carboxylase (ACC) isozymes.
    Cheng D; Chu CH; Chen L; Feder JN; Mintier GA; Wu Y; Cook JW; Harpel MR; Locke GA; An Y; Tamura JK
    Protein Expr Purif; 2007 Jan; 51(1):11-21. PubMed ID: 16854592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virtual Screening Strategy Combined Bayesian Classification Model, Molecular Docking for Acetyl-CoA Carboxylases Inhibitors.
    Zhou WN; Zhang YM; Qiao X; Pan J; Yin LF; Zhu L; Zhao JN; Lu S; Lu T; Chen YD; Liu HC
    Curr Comput Aided Drug Des; 2019; 15(3):193-205. PubMed ID: 30411690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent development in acetyl-CoA carboxylase inhibitors and their potential as novel drugs.
    Wu X; Huang T
    Future Med Chem; 2020 Mar; 12(6):533-561. PubMed ID: 32048880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and structure-activity relationships of novel spiro-piperidines as acetyl-CoA carboxylase inhibitors.
    Kamata M; Yamashita T; Kina A; Funata M; Mizukami A; Sasaki M; Tani A; Funami M; Amano N; Fukatsu K
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3643-7. PubMed ID: 22560583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclohexanedione herbicides are inhibitors of rat heart acetyl-CoA carboxylase.
    Seng TW; Skillman TR; Yang N; Hammond C
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3237-42. PubMed ID: 12951100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant yeast screen for new inhibitors of human acetyl-CoA carboxylase 2 identifies potential drugs to treat obesity.
    Marjanovic J; Chalupska D; Patenode C; Coster A; Arnold E; Ye A; Anesi G; Lu Y; Okun I; Tkachenko S; Haselkorn R; Gornicki P
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9093-8. PubMed ID: 20439761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis.
    Mao J; DeMayo FJ; Li H; Abu-Elheiga L; Gu Z; Shaikenov TE; Kordari P; Chirala SS; Heird WC; Wakil SJ
    Proc Natl Acad Sci U S A; 2006 May; 103(22):8552-7. PubMed ID: 16717184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in mice.
    Gao YS; Qian MY; Wei QQ; Duan XB; Wang SL; Hu HY; Liu J; Pan CY; Zhang SQ; Qi LW; Zhou JP; Zhang HB; Wang LR
    Acta Pharmacol Sin; 2020 Mar; 41(3):336-347. PubMed ID: 31645659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spirolactam-based acetyl-CoA carboxylase inhibitors: toward improved metabolic stability of a chromanone lead structure.
    Griffith DA; Dow RL; Huard K; Edmonds DJ; Bagley SW; Polivkova J; Zeng D; Garcia-Irizarry CN; Southers JA; Esler W; Amor P; Loomis K; McPherson K; Bahnck KB; Préville C; Banks T; Moore DE; Mathiowetz AM; Menhaji-Klotz E; Smith AC; Doran SD; Beebe DA; Dunn MF
    J Med Chem; 2013 Sep; 56(17):7110-9. PubMed ID: 23981033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008.
    Corbett JW
    Expert Opin Ther Pat; 2009 Jul; 19(7):943-56. PubMed ID: 19552511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mislocalization and inhibition of acetyl-CoA carboxylase 1 by a synthetic small molecule.
    Jung D; Abu-Elheiga L; Ayuzawa R; Gu Z; Shirakawa T; Fujiki Y; Nakatsuji N; Wakil SJ; Uesugi M
    Biochem J; 2012 Dec; 448(3):409-16. PubMed ID: 23067267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors.
    Kamata M; Yamashita T; Kina A; Tawada M; Endo S; Mizukami A; Sasaki M; Tani A; Nakano Y; Watanabe Y; Furuyama N; Funami M; Amano N; Fukatsu K
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4769-72. PubMed ID: 22677317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver steatosis in hypothalamic obese rats improves after duodeno-jejunal bypass by reduction in de novo lipogenesis pathway.
    Soares GM; Cantelli KR; Balbo SL; Ribeiro RA; Alegre-Maller ACP; Barbosa-Sampaio HC; Boschero AC; Araújo ACF; Bonfleur ML
    Life Sci; 2017 Nov; 188():68-75. PubMed ID: 28866102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.